Issue 9/2003
Content (7 Articles)
Impact of the tumor microenvironment on host infiltrating cells and the efficacy of flt3-ligand combination immunotherapy evaluated in a treatment model of mouse prostate cancer
Richard P. Ciavarra, Roy R. Brown, Daniel A. Holterman, Marianne Garrett, William F. Glass II, George L. Wright Jr., Paul F. Schellhammer, Kenneth D. Somers
CD26 expression determines lung metastasis in mutant F344 rats: involvement of NK cell function and soluble CD26
Kiyoshi Shingu, Andreas Helfritz, Margot Zielinska-Skowronek, Dirk Meyer-Olson, Roland Jacobs, Reinhold E. Schmidt, Rolf Mentlein, Reinhard Pabst, Stephan von Hörsten
Life-prolonging effect of immunocell BAK (BRM-activated killer) therapy for advanced solid cancer patients: prognostic significance of serum immunosuppressive acidic protein levels
Takusaburo Ebina, Naoko Ogama, Hiroko Shimanuki, Tomoka Kubota, Noriko Isono
Streptococcal preparation OK-432: a new maturation factor of monocyte-derived dendritic cells for clinical use
Hideo Kuroki, Takashi Morisaki, Kotaro Matsumoto, Hideya Onishi, Eishi Baba, Masao Tanaka, Mitsuo Katano
Preclinical evaluation of anti-CD86 immunotoxin in rhesus monkeys: analysis of systemic toxicity, pharmacokinetics, and effect on primary T-cell responses
Henderikus G. Otten, Gijsbert C. de Gast, Wim C. Vooijs, Alexander P. van der Gouw, Mark de Boer, Mirjam A. Ossevoort, Margreet Jonker
Safety, biodistribution, pharmacokinetics, and immunogenicity of 99mTc-labeled humanized monoclonal antibody BIWA 4 (bivatuzumab) in patients with squamous cell carcinoma of the head and neck
David R. Colnot, Jan C. Roos, Remco de Bree, Abraham J. Wilhelm, J. Alain Kummer, Gertraud Hanft, Karl-Heinz Heider, Gerd Stehle, Gordon B. Snow, Guus A. M. S. van Dongen